HS Code:
(RS)-1-p-Chlorophenyl-4,4-dimethyl-3-(1H-1,2,4-triazol-1-ylmethyl)pentan-3-ol, commonly known as Tebuconazole (CAS No. 107534-96-3), is a systemic fungicide belonging to the triazole class of chemicals. Classified under HS Code 2933.99.22, it is widely used in agriculture to protect crops from fungal diseases by inhibiting ergosterol biosynthesis, a critical component of fungal cell membranes. Tebuconazole is effective against a broad spectrum of pathogens and is applied to cereals, fruits, vegetables, and other crops. It is traded globally as an active ingredient in pesticide formulations or as a standalone chemical compound for agricultural use.
Total Trade Volume
Approximately $1.2 billion USD
Data from 2022
Source
Data compiled from UN Comtrade, ITC Trade Map, and industry reports
$450 million USD
37.5% of total trade of total trade
Increasing
$250 million USD
20.8% of total trade of total trade
Stable
$180 million USD
15.0% of total trade of total trade
Increasing
$120 million USD
10.0% of total trade of total trade
Stable
$80 million USD
6.7% of total trade of total trade
Increasing
Average Rate
5.5% ad valorem
Highest Rate
12% (imposed by certain developing countries with protective agricultural policies)
Lowest Rate
0% (under free trade agreements like EU-US TTIP or within ASEAN)
Growing demand in developing economies
Increased agricultural productivity needs in countries like India and Brazil drive higher imports and domestic production of Tebuconazole, boosting trade volumes by 8-10% annually.
2021-2023
Shift towards sustainable alternatives
Rising environmental concerns and stricter regulations in the EU and North America are pushing research into biofungicides, potentially reducing Tebuconazole demand by 5% over the next decade.
2022-2023
Price volatility due to supply chain disruptions
Post-COVID supply chain issues and geopolitical tensions have led to fluctuating raw material costs, impacting Tebuconazole prices by up to 15% in key markets.
2021-2022
The European Union conducted a reassessment of Tebuconazole due to concerns over endocrine disruption and environmental persistence, leading to tighter usage restrictions in member states.
March 2023
Reduced exports to EU markets by approximately 10%, prompting exporters to target alternative regions like Asia-Pacific.
Major Chinese manufacturers announced plans to increase Tebuconazole production capacity by 20% to meet rising global demand, particularly from Latin America and Africa.
July 2022
Expected to stabilize global prices and enhance Chinaโs dominance in the market, potentially increasing its trade share to 40% by 2025.
The US Environmental Protection Agency (EPA) updated its residue tolerance levels for Tebuconazole on certain crops, aligning with international standards to facilitate trade.
October 2022
Simplified export processes for US-based suppliers, potentially increasing trade volume by 5% in North American markets.